-
Genetically Engineered CAR T Cells Prove Highly Effective Against Blood Cancers
The era of powerful, personalized medicine draws near.
-
Cancer Immunotherapy Reverses Alzheimer’s in Mice
A checkpoint inhibitor may offer hope for Alzheimer’s patients.
-
FDA Approval Expands Immunotherapy Options for Advanced Melanoma
Immunotherapy combinations continue to shine against melanoma.
-
Biden’s Cancer “Moonshot”: PBS Interview with CRI Scientist
Vice President Joe Biden declared that we are going to take a “moonshot” at cancer, to cure…
-
CRI Scientific Advisory Council Member Elected NAI Fellow
Pramod K. Srivastava, MD, PhD, a CRI Scientific Advisory Council member, was elected a Fellow in the National…
-
CRI Partners with the Lymphoma Research Foundation to Improve Immunotherapy Evaluation Guidelines for Lymphoma
CRI, LRF work towards better immunotherapy guidelines for lymphoma.
-
Second Antibody FDA-Approved Against Multiple Myeloma
Elotuzumab (Empliciti) is the second antibody for myeloma approved in just two weeks.
-
Nivolumab Becomes First FDA-Approved Checkpoint Blockade for Kidney Cancer
New hope now exists for patients with advanced kidney cancer.
-
Second Annual Immuno-Oncology 360° Conference
CRI Scientific Advisory Council member to co-chair two-day conference devoted to cancer immunotherapy.
